Wegovy Slashes the Risk of Heart Attack and Stroke in a Landmark Trial

https://media.wired.com/photos/654ec8225c5bbfd14d7b4d2c/master/pass/Wegovy-Heart-Disease-Science-1692436399.jpg

The drug semaglutide is already widely used for weight loss. Now its maker is presenting new evidence that it can reduce cardiovascular illnesses and deaths.

https://www.wired.com/story/wegovy-slashes-the-risk-of-heart-attack-and-stroke-in-a-landmark-trial/ 

 Fix the underlying problem and stop looking for a quick fix